chartexchange

BCTX
Briacell Therapeutics Corp. Common Shares
stockNASDAQ

At CloseNov 17, 2026 2:17:37 PM EST
3.49USD+5.758%(+0.19)116,057
Pre-marketNov 17, 2026 9:25:30 AM EST
3.30USD0.000%(0.00)
After-hoursNov 17, 2026 4:37:30 PM EST
3.45USD-1.146%(-0.04)
2.9600Bid4.0300Ask1.0700Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
West Vancouver, BC, Canada
Previous Close
$3.30
Beta
1.58
52-Week High
$13.09 2025-12-09
52-Week Low
$2.60 2026-06-11
SMA 50
$3.71
SMA 200
$3.76
Avg. Vol 10D
63,747
Avg. Vol 30D
60,296
Avg. Vol 90D
213,008
Relative Vol
1.86
7.96M
18.4100%
1,871
Dec 10, 2026 (23d)
Aug 25, 2025 · 1-for-10 (reverse)
BCTX Profile

briacell therapeutics corp immunotherapy approaches to cancer management briacell is a los angeles headquartered biotechnology company focused on immunotherapy treatments for cancer management. to date, the company has been successful in developing its patented "briavax" vaccine and implementing two compelling fda phase-i studies with late-stage breast cancer patients, demonstrating unique and unprecedented results. briacell is focused on aggressively moving towards launching its next clinical trial, a phase-i/ii study, in order to apply its vaccine to a larger number of breast cancer patients and effectively progress its technology along the value chain. while the current corporate focus is breast cancer, the company has an eye towards potentially applying its vaccine technology to certain other cancer types as well.

BCTX Performance
PeriodPriceDateChangeBeta
1W3.692026-11-10-4.20%-0.014
1M3.402026-10-16+3.97%0.533
3M3.392026-08-17+4.28%1.040
6M3.352026-05-18+5.52%1.000
1Y8.072025-11-17-56.20%1.577
2Y89.252024-11-18-96.04%—
5Y1,515.002021-11-17-99.77%0.939
BCTX Stock Summary

Briacell Therapeutics Corp. Common Shares (NASDAQ:BCTX) stock price today is $3.54, and today's volume is 111,963. BCTX is up 7.121% today. The 30 day average volume is 60,296. BCTX market cap is $30.87M with 8.73M shares outstanding.